Growth Metrics

Eli Lilly (LLY) Operating Margin Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 660.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -179.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -138.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -6,345.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 1,648.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 360.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 2,760.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -103.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 660.00
Dec 31, 2025 671.00
Sep 30, 2025 752.00
Jun 30, 2025 1,090.00
Mar 31, 2025 1,150.00
Dec 31, 2024 726.00
Sep 30, 2024 199.00
Jun 30, 2024 749.00
Mar 31, 2024 690.00
Dec 31, 2023 374.00
Sep 30, 2023 1,101.00
Jun 30, 2023 130.00
Mar 31, 2023 -993.00
Dec 31, 2022 -100.00
Sep 30, 2022 -535.00
Jun 30, 2022 398.00
Mar 31, 2022 1,135.00
Dec 31, 2021 -373.00
Sep 30, 2021 813.00
Jun 30, 2021 -470.00
Mar 31, 2021 -648.00
Dec 31, 2020 779.00
Sep 30, 2020 -527.00
Jun 30, 2020 -87.00
Mar 31, 2020 436.00
Dec 31, 2019 16.00
Sep 30, 2019 86.00
Jun 30, 2019 -152.00
Mar 31, 2019 -358.00
Dec 31, 2018 534.00
Sep 30, 2018 630.00
Jun 30, 2018 708.00
Mar 31, 2018 709.00
Dec 31, 2017 160.00
Sep 30, 2017 133.00
Jun 30, 2017 331.00
Mar 31, 2017 275.00
Dec 31, 2016 446.00
Sep 30, 2016 -119.00
Jun 30, 2016 -103.00
Mar 31, 2016 -173.00
Dec 31, 2015 -340.00
Sep 30, 2015 602.00
Jun 30, 2015 123.00
Mar 31, 2015 65.00
Dec 31, 2014 13.00
Sep 30, 2014 -1,254.00
Jun 30, 2014 -845.00
Mar 31, 2014 -727.00
Dec 31, 2013 -419.00
Sep 30, 2013 583.00
Jun 30, 2013 495.00
Mar 31, 2013 69.00
Dec 31, 2012 362.00
Sep 30, 2012 -486.00
Jun 30, 2012 -395.00
Mar 31, 2012 -357.00
Dec 31, 2011 -575.00
Sep 30, 2011 -200.00
Jun 30, 2011 -313.00
Mar 31, 2011 -203.00
Dec 31, 2010 160.00
Sep 30, 2010 997.00
Jun 30, 2010 36.00
Mar 31, 2010 -407.00